Concepedia

Publication | Open Access

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers

DOIFull Paper Access

107

Citations

24

References

2016

Year

Milan Radovich, Patrick J. Kiel, Stacy Marie Nance, Erin Niland, Megan E. Parsley, Meagan Ferguson, Guanglong Jiang, Natraj Reddy Ammakkanavar, Lawrence H. Einhorn, Liang Cheng,
Oncotarget

Abstract

Patients with refractory metastatic cancer who receive genomically guided therapy have improved PFS ratios and longer median PFS compared to patients who do not receive genomically guided therapy.

References

YearCitations

Page 1